Chemical exchange saturation transfer for predicting response to stereotactic radiosurgery in human brain metastasis

The purpose of this work was to determine the predictive value of chemical exchange saturation transfer (CEST) metrics in brain metastases treated with stereotactic radiosurgery (SRS).

[1]  Jing Yuan,et al.  APT‐weighted and NOE‐weighted image contrasts in glioma with different RF saturation powers based on magnetization transfer ratio asymmetry analyses , 2013, Magnetic resonance in medicine.

[2]  M. Symms,et al.  A simple correction for B1 field errors in magnetization transfer ratio measurements. , 2006, Magnetic resonance imaging.

[3]  D. Kondziolka,et al.  The role of stereotactic radiosurgery in the management of patients with newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline , 2009, Journal of Neuro-Oncology.

[4]  Jinyuan Zhou,et al.  Amide proton transfer imaging of 9L gliosarcoma and human glioblastoma xenografts , 2008, NMR in biomedicine.

[5]  P Vaupel,et al.  Oxygen status of malignant tumors: pathogenesis of hypoxia and significance for tumor therapy. , 2001, Seminars in oncology.

[6]  Michael Brady,et al.  MIND: Modality independent neighbourhood descriptor for multi-modal deformable registration , 2012, Medical Image Anal..

[7]  S. Brockstedt,et al.  Tumor extension in high-grade gliomas assessed with diffusion magnetic resonance imaging: values and lesion-to-brain ratios of apparent diffusion coefficient and fractional anisotropy , 2006, Acta radiologica.

[8]  Daniel Paech,et al.  Correction of B1‐inhomogeneities for relaxation‐compensated CEST imaging at 7 T , 2015, NMR in biomedicine.

[9]  Daniel Paech,et al.  Nuclear Overhauser Enhancement Imaging of Glioblastoma at 7 Tesla: Region Specific Correlation with Apparent Diffusion Coefficient and Histology , 2015, PloS one.

[10]  E. Oermann,et al.  The volumetric response of brain metastases after stereotactic radiosurgery and its post-treatment implications. , 2014, Neurosurgery.

[11]  A. Elhan,et al.  Evaluation of cerebral glioma grade by using normal side creatine as an internal reference in multi-voxel 1H-MR spectroscopy. , 2007, Diagnostic and interventional radiology.

[12]  S. Vermeulen,et al.  The management of brain necrosis as a result of SRS treatment for intra-cranial tumors , 2014 .

[13]  J. Gore,et al.  Studies of magnetization transfer and relaxation in irradiated polymer gels - interpretation of MRI-based dosimetry , 2001, Physics in medicine and biology.

[14]  Hye-Young Heo,et al.  Quantitative assessment of amide proton transfer (APT) and nuclear overhauser enhancement (NOE) imaging with extrapolated semi‐solid magnetization transfer reference (EMR) signals: Application to a rat glioma model at 4.7 tesla , 2016, Magnetic resonance in medicine.

[15]  Jinyuan Zhou,et al.  Practical data acquisition method for human brain tumor amide proton transfer (APT) imaging , 2008, Magnetic resonance in medicine.

[16]  Kimberly L Desmond,et al.  Mapping of amide, amine, and aliphatic peaks in the CEST spectra of murine xenografts at 7 T , 2014, Magnetic resonance in medicine.

[17]  J. Knisely,et al.  A Comprehensive Review of MR Imaging Changes following Radiosurgery to 500 Brain Metastases , 2011, American Journal of Neuroradiology.

[18]  Martin Bendszus,et al.  Response assessment criteria for brain metastases: proposal from the RANO group. , 2015, The Lancet. Oncology.

[19]  A Gregory Sorensen,et al.  Imaging pH using the chemical exchange saturation transfer (CEST) MRI: Correction of concomitant RF irradiation effects to quantify CEST MRI for chemical exchange rate and pH , 2008, Magnetic resonance in medicine.

[20]  Jinyuan Zhou,et al.  Three‐dimensional amide proton transfer MR imaging of gliomas: Initial experience and comparison with gadolinium enhancement , 2013, Journal of magnetic resonance imaging : JMRI.

[21]  Daniel L. Polders,et al.  Amide proton transfer (APT) imaging of brain tumors at 7 T: The role of tissue water T1‐Relaxation properties , 2017, Magnetic resonance in medicine.

[22]  Jinyuan Zhou,et al.  MR imaging of high-grade brain tumors using endogenous protein and peptide-based contrast , 2010, NeuroImage.

[23]  Makoto Ochi,et al.  Differentiation between high-grade glioma and metastatic brain tumor using single-voxel proton MR spectroscopy , 2001, European Radiology.

[24]  Edward Pan,et al.  In vivo chemical exchange saturation transfer imaging allows early detection of a therapeutic response in glioblastoma , 2014, Proceedings of the National Academy of Sciences.

[25]  Tao Jin,et al.  MR imaging of the amide‐proton transfer effect and the pH‐insensitive nuclear overhauser effect at 9.4 T , 2013, Magnetic resonance in medicine.

[26]  Jinyuan Zhou,et al.  Amide proton transfer MR imaging of prostate cancer: A preliminary study , 2011, Journal of magnetic resonance imaging : JMRI.

[27]  Liane Oehme,et al.  A method for model-free partial volume correction in oncological PET , 2012, EJNMMI Research.

[28]  D. Kondziolka,et al.  MR imaging response of brain metastases after gamma knife stereotactic radiosurgery. , 1999, Radiology.

[29]  D. Rigamonti,et al.  Imaging changes following stereotactic radiosurgery for metastatic intracranial tumors: differentiating pseudoprogression from tumor progression and its effect on clinical practice , 2014, Neurosurgical Review.

[30]  Ravinder Reddy,et al.  CEST signal at 2 ppm (CEST@2ppm) from Z‐spectral fitting correlates with creatine distribution in brain tumor , 2014, NMR in biomedicine.

[31]  Erik Tryggestad,et al.  Differentiation between glioma and radiation necrosis using molecular magnetic resonance imaging of endogenous proteins and peptides , 2010, Nature Medicine.

[32]  R M Henkelman,et al.  Quantitative interpretation of magnetization transfer , 1993, Magnetic resonance in medicine.

[33]  Richard A. E. Edden,et al.  Nuclear Overhauser enhancement (NOE) imaging in the human brain at 7T , 2013, NeuroImage.

[34]  C. Stippich,et al.  Primary motor cortex activation and lateralization in patients with tumors of the central region☆ , 2013, NeuroImage: Clinical.

[35]  Jinyuan Zhou,et al.  Amide proton transfer (APT) contrast for imaging of brain tumors , 2003, Magnetic resonance in medicine.

[36]  P. Desmond,et al.  Diffusion Tensor Imaging in Glioblastoma Multiforme and Brain Metastases: The Role of p, q, L, and Fractional Anisotropy , 2008, American Journal of Neuroradiology.

[37]  Michael Brady,et al.  Improved Optimization for the Robust and Accurate Linear Registration and Motion Correction of Brain Images , 2002, NeuroImage.

[38]  Koji Yamashita,et al.  Amide proton transfer imaging of adult diffuse gliomas: correlation with histopathological grades. , 2014, Neuro-oncology.

[39]  J. Borén,et al.  Apoptosis-induced mitochondrial dysfunction causes cytoplasmic lipid droplet formation , 2012, Cell Death and Differentiation.

[40]  A. Okumura,et al.  The characterization of human brain tumor using magnetization transfer technique in magnetic resonance imaging. , 1999, Neurological research.

[41]  R. Boellaard,et al.  Reproducibility of quantitative (R)-[11C]verapamil studies , 2012, EJNMMI Research.

[42]  Stephen M. Smith,et al.  A global optimisation method for robust affine registration of brain images , 2001, Medical Image Anal..

[43]  J G Pipe,et al.  In vivo MR determination of water diffusion coefficients and diffusion anisotropy: correlation with structural alteration in gliomas of the cerebral hemispheres. , 1995, AJNR. American journal of neuroradiology.

[44]  T. Hirai,et al.  Diffusion-weighted imaging of metastatic brain tumors: comparison with histologic type and tumor cellularity. , 2006, AJNR. American journal of neuroradiology.

[45]  Greg J. Stanisz,et al.  Diffusion MR in Biological Systems: Tissue Compartments and Exchange , 2010 .

[46]  Ravinder Reddy,et al.  Exchange rates of creatine kinase metabolites: feasibility of imaging creatine by chemical exchange saturation transfer MRI , 2012, NMR in biomedicine.

[47]  H. Critchley,et al.  Quantitative Magnetization Transfer Imaging as a Biomarker for Effects of Systemic Inflammation on the Brain , 2015, Biological Psychiatry.

[48]  Kimberly L Desmond,et al.  Understanding quantitative pulsed CEST in the presence of MT , 2012, Magnetic resonance in medicine.

[49]  Thomas E Yankeelov,et al.  Magnetic resonance in the era of molecular imaging of cancer. , 2011, Magnetic resonance imaging.

[50]  Christophe Ley,et al.  Detecting outliers: Do not use standard deviation around the mean, use absolute deviation around the median , 2013 .

[51]  Jinyuan Zhou,et al.  Using the amide proton signals of intracellular proteins and peptides to detect pH effects in MRI , 2003, Nature Medicine.

[52]  Brian D Ross,et al.  Predicting and monitoring cancer treatment response with diffusion‐weighted MRI , 2010, Journal of magnetic resonance imaging : JMRI.

[53]  Thomas E Yankeelov,et al.  Amide proton transfer imaging of the breast at 3 T: Establishing reproducibility and possible feasibility assessing chemotherapy response , 2013, Magnetic resonance in medicine.

[54]  L. Schwartz,et al.  New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). , 2009, European journal of cancer.

[55]  B. Bobek-Billewicz,et al.  Fibre integrity and diffusivity of the pyramidal tract and motor cortex within and adjacent to brain tumour in patients with or without neurological deficits. , 2011, Folia neuropathologica.

[56]  T L Chenevert,et al.  Monitoring early response of experimental brain tumors to therapy using diffusion magnetic resonance imaging. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

[57]  R S Balaban,et al.  Determination of pH using water protons and chemical exchange dependent saturation transfer (CEST) , 2000, Magnetic resonance in medicine.

[58]  M. Pui,et al.  Magnetization transfer analysis of brain tumor, infection, and infarction , 2000, Journal of magnetic resonance imaging : JMRI.